Commerce Dashboard

GlaxoSmithKline Pharmaceuticals Ltd.

Go Back

GlaxoSmithKline Pharmaceuticals Ltd.

  • In India, they are one of the market leaders with a turnover of Rs 2,520.2 crore (US$ 402.37 million).
  • Market share of 3.55 per cent.
  • SmithKline and Beecham becomes a public limited company under the new name of Eskayef Ltd.

Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 4,500 people. Globally, they are a £ 26.5 billion (US$ 39.14 billion), leading, research-based healthcare and pharmaceutical company. In India, they are one of the market leaders with a turnover of Rs 2,520.2 crore (US$ 402.37 million) and a share of 3.55 per cent. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.


GlaxoSmithKline: Developing new and effective healthcare solutions

2014 GSK India named as one of 'India's Most Admired Companies' by Fortune India in partnership with the Hays Group.
2013 Fourth CII National HR Excellence Award for 'Significant achievement in HR Excellence'
2012 Awarded the Paediatrician's Award for the Best Vaccine Company of the Year by Frost & Sullivan.
2011 Pharma / Life - Science Supply Chain Excellence Award presented at the 5thExpress, Logistics and Supply Chain Conclave.
2003 GlaxoSmithKline named as India's most respected Pharmaceutical Company in a survey conducted by BusinessWorld and the Indian Market Research Bureau (IMRB)
India ranks 3rd worldwide for pharmaceutical production by volume and 14th by value. The country has an established domestic pharmaceutical industry, with a strong network of 3,000 drug companies and ~10,500 manufacturing units.